Premium
The induction and characterization of monoclonal antibodies specific to GP of Ebola virus
Author(s) -
Tian Xiaoyan,
Chen Deyan,
Wang Huanru,
Xu Shijie,
Zhu Linjing,
Wu Xilin,
Wu Zhiwei
Publication year - 2020
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.25615
Subject(s) - monoclonal antibody , ebola virus , virology , epitope , antibody , virus , glycoprotein , neutralization , polyclonal antibodies , antiserum , western blot , biology , ebolavirus , monoclonal , microbiology and biotechnology , immunology , biochemistry , gene
Abstract The Ebola virus is highly infectious and characterized by hemorrhagic fever, headache, and so on with a high mortality rate. Currently, there are neither therapeutic drugs or vaccines against the Ebola virus nor fast diagnostic methods for the detection of Ebola virus infection. This study reported the induction and isolation of two monoclonal antibodies that specifically recognized the glycoprotein (GP) and secreted glycoprotein (sGP) of the Ebola virus. Plasmids encoding either GP or sGP were constructed and immunized BALB/c mice, accordingly purified sGP was boosted. The antisera were analyzed for binding activity against sGP protein in enzyme‐linked immunosorbent assay (ELISA) and neutralization activity in a pseudotyped virus neutralization assay. A number of reactive clones were isolated and two monoclonal antibodies T231 and T242 were identified to react with both GP and sGP. Western blot and ELISA assays showed that the monoclonal antibodies could react with GP and sGP, respectively. Moreover, they could recognize Ebola pseudovirus by cellular immunochemistry assay. We labeled the monoclonal antibody T231 with biotin and analyzed the competitiveness of the two antibodies by the ELISA test. The results showed that the binding epitopes of the two monoclonal antibodies to sGP were partially overlapped. In summary, two GP‐specific mAbs were identified, which will be used to detect the Ebola virus or investigate GP.